June 2026 Regulatory Roundup: New Drugs and NWS

Erica Wassack, PharmD, DICVP, FACVP
Regulatory & Governmental Affairs Liaison

The following updates summarize recent FDA activity relevant to pharmacy and veterinary practice. Please review and share with your team as appropriate.

New Drug Approvals:

Amodip (amlodipine besylate) chewable tablet – Control of systemic hypertension in cats
Tessie (tasipimidine) oral solution – Treatment of noise aversion and separation anxiety in dogs

Conditional Drug Approvals:

Liavium-CA1 (pregabalin) chewable tablet – Management of pain and clinical signs associated with Chiari-like malformation and syringomyelia in dogs

Emergency Use Authorization:

Dectomax & Dectomax-CA1 (doramectin) injection for prevention and treatment of New World screwworm (NWS) infestations

Read more here: https://www.aphis.usda.gov/animals/animal-health/livestock-and-poultry-disease/current-status/us-confirmed-cases-new-world

For full guidance documents and official announcements, please refer to the FDA website.